4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-010973
See Remarks sold 15,843 shares at $3.84 ($60,915)
- See Remarks acquired 44,367 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Corcoran Andrea See Remarks | 2024-01-31 | Option exercise | +44,367 | 686,051 | D | ||
| Corcoran Andrea See Remarks | 2024-02-01 | Sale | −15,843 | $3.84 | $60,915 | 670,208 | D |
| Derivatives | |||||||
| Corcoran Andrea See Remarks | 2024-01-31 | Option exercise · Restricted Stock Units | −44,367 | 88,733 | D | ||
| Corcoran Andrea See Remarks | 2024-01-31 | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | D | ||
| Open-market sales · 15,843 sh · avg $3.84 · $60,915 | |||||||
Loading xslF345X05/ownership.xml…